Literature DB >> 23474455

Synthesis of Fondaparinux: modular synthesis investigation for heparin synthesis.

Feng Lin1, Gaoyan Lian, Ying Zhou.   

Abstract

The anti-thromboembolic pentasaccharide Fondaparinux was synthesized in 36 steps for the longest linear route, with 0.017% overall yield from D-glucose. Only three kinds of protecting groups were used for hydroxyl protection, Bn, Ac, and Bz, to accomplish this complex synthesis without decreasing the synthetic efficiency. Three L-idopyranosyl donors were investigated. Thioethyl glycoside is an efficient donor for L-idopyranosyl glycosylation with full α-selectivity, while L-idopyranosyl trichloroacetimidate resulted in poor α/β selectivity. A practical synthesis of key intermediate 1,6-anhydro-L-idopyranose 17 by H(+)/β-CD catalyst was developed.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23474455     DOI: 10.1016/j.carres.2013.01.003

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  7 in total

1.  Programmable One-Pot Synthesis of Heparin Pentasaccharide Fondaparinux.

Authors:  Supriya Dey; Hong-Jay Lo; Chi-Huey Wong
Journal:  Org Lett       Date:  2020-06-04       Impact factor: 6.005

2.  Chemogenesis of an antiangiogenic glycosaminoglycan.

Authors:  Karthik Raman; Sailaja Arungundram; Balagurunathan Kuberan
Journal:  ACS Med Chem Lett       Date:  2014-04-04       Impact factor: 4.345

3.  Facile chemoenzymatic synthesis of biotinylated heparosan hexasaccharide.

Authors:  Baolin Wu; Na Wei; Vireak Thon; Mohui Wei; Zaikuan Yu; Yongmei Xu; Xi Chen; Jian Liu; Peng George Wang; Tiehai Li
Journal:  Org Biomol Chem       Date:  2015-05-14       Impact factor: 3.876

Review 4.  Advances in the preparation and synthesis of heparin and related products.

Authors:  Sultan N Baytas; Robert J Linhardt
Journal:  Drug Discov Today       Date:  2020-09-16       Impact factor: 7.851

5.  Optimization of bioengineered heparin/heparan sulfate production for therapeutic applications.

Authors:  Megan S Lord; MoonSun Jung; John M Whitelock
Journal:  Bioengineered       Date:  2017-04-10       Impact factor: 3.269

6.  Bioengineered heparin: is there a future for this form of the successful therapeutic?

Authors:  Megan S Lord; John M Whitelock
Journal:  Bioengineered       Date:  2014-06-05       Impact factor: 3.269

7.  Total Synthesis of a Partial Structure from Arabinogalactan and Its Application for Allergy Prevention.

Authors:  Matthias Krumb; Maximilian Jäger; Alice Voss; Loreen Immig; Karin Peters; Danuta Kowalczyk; Albrecht Bufe; Till Opatz; Otto Holst; Christian Vogel; Marcus Peters
Journal:  Chemistry       Date:  2020-10-27       Impact factor: 5.020

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.